Healthcare enterprise Centene (NYSE:CNC) said on Tuesday that the 2015 earnings per diluted share, excluding Health Net merger related costs, is expected to exceed its prior range of USD2.90 to USD2.94.
The company recorded total revenues of USD22.8bn and diluted earnings per share (EPS) of USD2.89 in 2015.
For its 2016 fiscal year, the company expects total revenues in the range of USD41.2bn to USD42.0bn; GAAP earnings per diluted share of approximately USD2.85 to USD3.15; As well as adjusted earnings per diluted share of approximately USD4.10 to USD4.40.
In conjunction, the company will disclose its full 2015 fourth quarter and year-end financial results at 6:00 (Eastern Time) on 9 February 2016.
Eli Lilly announces Q1 2026 dividend
Amgen announces Q4 2025 dividend
Bavarian Nordic secures new EU contract for up to 8 million smallpox and mpox vaccine doses
Thermo Fisher Scientific to acquire Clario Holdings, expanding clinical data capabilities
Nanoform and Revio Therapeutics partner to develop long-acting hydrogel therapy for glioma
Cumberland Pharmaceuticals adds FDA-approved oral capsule for H. pylori to commercial portfolio
IP Group positions for future royalties following Pfizer's USD7.3bn acquisition of Metsera
AstraZeneca strikes landmark drug pricing deal with US Government